Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Human Metabolome Tech, First Half Ordinary Profit Decreases by 50%
6090 Human Metabolome Technologies, Inc. 【J-GAAP】
Earnings ReportHuman Metabolome Technologies, Inc. <6090> [TSE Std] announced its financial results after the market closed on February 12th (15:30). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending June 2026 (July to December) dropped 50.0% from the same period last year to 47 million yen. Progress toward the full-year plan of 300 million yen was 15.7%, also falling below the five-year average of 34.4%.
Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to June period (second half) is expected to expand 73.3% from the same period last year, reaching 253 million yen.
In the most recent three-month period, from October to December (2Q), the consolidated ordinary profit grew 26.9% from the same period last year, reaching 137 million yen. The operating profit margin rose from 26.6% in the same period last year to 29.3%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jul - Dec, 2023 | 632 | 71 | 70 | 71 | 12.0 | 29.0 | Feb 14, 2024 | J-GAAP |
| Jul - Dec, 2024 | 684 | 104 | 94 | 93 | 15.8 | 39.2 | Feb 13, 2025 | J-GAAP |
| Jul - Dec, 2025 | 659 | 46 | 47 | 43 | 7.7 | 15.7 | Feb 12, 2026 | J-GAAP |
| YoY | -3.7% | -55.8% | -50.0% | -53.8% | -50.9% |
First Half Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jul - Dec, 2025 Guidance | ー | ー | ー | ー | - | 0 | Aug 8, 2025 | J-GAAP |
| Jul - Dec, 2025 Results | 659 | 46 | 47 | 43 | 7.7 | 0 | Feb 12, 2026 | J-GAAP |
| Revision Rate | - | - | - | - | - |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Jun, 2025 | 771 | 145 | 146 | 163 | 27.8 | 15 | Aug 8, 2025 | J-GAAP |
| Jan - Jun, 2026 Guidance | 941 | 254 | 253 | 217 | 38.6 | 18 | Feb 12, 2026 | J-GAAP |
| YoY | +22.0% | +75.2% | +73.3% | +33.1% | +38.7% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jun, 2024 | 1,345 | 220 | 241 | 243 | 41.1 | 15 | Aug 9, 2024 | J-GAAP |
| Jun, 2025 | 1,455 | 249 | 240 | 256 | 43.7 | 15 | Aug 8, 2025 | J-GAAP |
| Jun, 2026 Guidance | 1,600 | 300 | 300 | 260 | 46.2 | 18 | Aug 8, 2025 | J-GAAP |
| YoY | +10.0% | +20.5% | +25.0% | +1.6% | +5.8% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Dec, 2024 | 410 | 109 | 108 | 128 | 21.7 | 26.6 | Feb 13, 2025 | J-GAAP |
| Jan - Mar, 2025 | 582 | 249 | 248 | 211 | 35.8 | 42.8 | May 14, 2025 | J-GAAP |
| Apr - Jun, 2025 | 189 | -104 | -102 | -48 | -8.2 | -55.0 | Aug 8, 2025 | J-GAAP |
| Jul - Sep, 2025 | 192 | -91 | -90 | -97 | -17.1 | -47.4 | Nov 12, 2025 | J-GAAP |
| Oct - Dec, 2025 | 467 | 137 | 137 | 140 | 25.2 | 29.3 | Feb 12, 2026 | J-GAAP |
| YoY | +13.9% | +25.7% | +26.9% | +9.4% | +16.2% |
Related Articles
ReproCELL, Ordinary Profit Forecast for the Fiscal Year Loss Widened in Downward Revision
Monex Group, Apr-Dec (Cumulative 3Q) Net Income Turns to Profit, Oct-Dec Net Income Turns to Profit
ROHTO PHARMA, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 6%, Exceeded Record Profit Forecast, Dividend Revised Upward by 1 Yen
CRI Middleware, Oct-Dec (1Q) Ordinary Profit Decreases by 74%
ExaWizards, Apr-Dec (Cumulative 3Q) Ordinary Profit Turns to Profit, Oct-Dec Ordinary Profit Increases by 237 times
NETSTARS, 60% Increase in Ordinary Profit, Update Record High for Second Consecutive Term
MEIWA INDUSTRY, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 10%, Oct-Dec Ordinary Profit Decreases by 83%
Relo Group, Apr-Dec (Cumulative 3Q) Net Income Decreases by 61%
PIOLAX, Ordinary Profit Forecast for the Fiscal Year Revised Downward by 25%
TBK, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 30%